Moorfields Eye Hospital NHS Foundation Trust has appointed Nick Strouthidis to the post of medical director. Currently a consultant ophthalmologist in Moorfields’ glaucoma service and the glaucoma service director, Nick has worked for the Trust since 2002.
Nick began his career at Moorfields as a research fellow to the glaucoma research unit and completed most of his training at Moorfields as both a registrar and a clinical glaucoma fellow. His clinical interests cover all aspects of adult glaucoma, particularly new surgical treatments. Alongside corneal consultant colleague Mark Wilkins, he runs the UK’s first integrated clinic for patients undergoing keratoprostheses, a surgical procedure to replace a diseased cornea with an artificial cornea.
Nick was appointed to this pivotal role following a rigorous recruitment process, involving external stakeholders.
Nick Strouthidis said:
“It is an honour to take on the role of medical director at Moorfields Eye Hospital NHS Foundation Trust, an organisation that has shaped my professional life. I will work hard with our incredible staff to ensure we succeed in delivering our five-year strategy to work with patients and partners to discover, develop and deliver the best eye care.”
The search for a new medical director began in response to outgoing medical director Declan Flanagan stepping down after eight years to focus on his clinical practice. Declan will continue to serve as medical director until August, when Nick takes up the post. After that, Declan will remain with the trust as a consultant ophthalmologist in the medical retina service, where he specialises in the treatment of retinal diseases.
David Probert, chief executive of Moorfields Hospital NHS Foundation Trust said:
“I look forward to Nick joining the executive team at Moorfields and congratulate him on his appointment. I am incredibly grateful for Declan’s exceptional leadership throughout his time as medical director.”
Declan Flanagan said: “Spending the past eight years as Moorfields’ medical director has been a privilege. I am proud that, despite growing demand for our services, our clinical outcomes continue to be among the best in the world.”
Notes to editors
For more information, please contact the Moorfields Eye Hospital press office on email@example.com or call 020 7566 2628. For out of hours enquiries please call 020 7253 3411 to speak to the on call press officer.
Images of Nick Strouthidis and Declan Flanagan are available on request.
· Moorfields Eye Hospital NHS Foundation Trust is a world-leading provider of eye care services in the UK. We provide a wide range of clinical services, caring for patients in over 30 locations in and around London to provide expert treatment closer to patients’ homes. We also operate commercial divisions that provide care to private patients in both London and the Middle East. With our academic partner, the UCL Institute of Ophthalmology, we are recognised as a leading centre of excellence in eye research and education. To find out more go to: www.moorfields.nhs.uk
· Nick Strouthidis is a consultant ophthalmologist in Moorfields’ glaucoma service, the glaucoma service director and deputy divisional director for the Trust’s City Road site.
Nick began his career at Moorfields as a research fellow to the glaucoma research unit in 2002 and completed most of his training at Moorfields as both a registrar and as a clinical glaucoma fellow.
His clinical interests cover all aspects of adult glaucoma, particularly new surgical treatments for glaucoma and, alongside corneal consultant colleague Mr Mark Wilkins, he runs the UK’s first integrated clinic for patients undergoing keratoprostheses, a surgical procedure to replace a diseased cornea with an artificial cornea.
He has a research interest in the optic nerve in glaucoma, having been awarded both an M.D. and PhD from UCL, based on clinical and basic science research in this field.
Nick is a Trustee of the International Glaucoma Association, an associate professor of Sydney University Medical School and sits on the editorial board of the British Journal of Ophthalmology. He lives in Chelsea with his wife, another glaucoma consultant, and daughter.
· Declan Flanagan joined Moorfields Eye Hospital in 2005 as a consultant ophthalmologist in the medical retina service. He was appointed deputy medical director in 2007 and medical director in 2009.
Under Declan’s guidance, Moorfields introduced the UK’s first nurse-led intravitreal injection service in 2012 to help meet increasing demand for patients needing urgent treatment for conditions including age-related macular degeneration. This multidisciplinary service model represented an important change in UK ophthalmology practice and allowed patients to be seen and treated more quickly. The model has now been adopted as one of the only sustainable methods of delivering intravitreal treatments across the UK. Moorfields now delivers three times as many intravitreal injections compared to five years ago.
Declan has made a significant contribution to improving quality and safety standards in ophthalmology during his time as medical director. He has taken the lead in regularly publishing outcome data for all major areas of ophthalmic care at Moorfields that are now used worldwide and benchmarked by many major eye centres worldwide. He was also instrumental in helping the trust achieve a rating of ‘good’ from the Care Quality Commission (CQC) following an inspection in 2016.
Was this information useful? Please rate the page.